A Cohort of Patients With Phenotyped Diffuse Interstitial Lung Disease With Longitudinal Follow-up
Sponsor
Centre Hospitalier Universitaire de Nice (Other)
Overall Status
Recruiting
CT.gov ID
NCT05810493
Collaborator
(none)
1,500
1
48
31.3
Study Details
Study Description
Brief Summary
The purpose of the study is to conduct a descriptive analysis of the population of patients with an interstitial lung disease received in the pulmonary department of University hospital of Nice (France). Analysis and documentation of clinical forms of the disease, therapeutics used and evolutions.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Study Design
Study Type:
Observational
Anticipated Enrollment
:
1500 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
A Cohort of Patients With Phenotyped Diffuse Interstitial Lung Disease With Longitudinal Follow-up
Actual Study Start Date
:
Jan 1, 2022
Anticipated Primary Completion Date
:
Dec 31, 2025
Anticipated Study Completion Date
:
Dec 31, 2025
Outcome Measures
Primary Outcome Measures
- Build a retrospective cohort of patients with phenotyped interstitial Lung disease with longitudinal follow-up [2 years]
Secondary Outcome Measures
- Follow-up of progression criteria according to diagnosis [2 years]
Change in pulmonary functional tests
- Follow-up of progression criteria according to diagnosis [2 years]
Change in respiratory symptoms
- Follow-up of progression criteria according to diagnosis [2 years]
Change in High-resolution Computed Tomography (HRCT) images
- Follow-up of progression criteria according to diagnosis [2 years]
Impact of interstitial lung disease treatements
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
-
Age ≥ 18 years old
-
Diagnosis of interstitial lung disease according to the multidisciplinary monthly meeting for interstitial lung disease occuring at University hospital of Nice, France
Exclusion Criteria:
- Patient-led opposition to data collection
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Sylvie LEROY | Nice | France | 06200 |
Sponsors and Collaborators
- Centre Hospitalier Universitaire de Nice
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Centre Hospitalier Universitaire de Nice
ClinicalTrials.gov Identifier:
NCT05810493
Other Study ID Numbers:
- 23Pneumo01
First Posted:
Apr 12, 2023
Last Update Posted:
Apr 12, 2023
Last Verified:
Mar 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms: